Prof. Pei-Wen Cheng | Medicinal Chemistry | Women Researcher Award

Published on by sciencefather

Prof. Pei-Wen Cheng | Medicinal Chemistry | Women Researcher Award

Prof. Pei-Wen Cheng is a distinguished academic and researcher specializing in nanomedicine, pharmacology, and metabolic syndrome. She has built a strong career through dedicated research and teaching, advancing innovative approaches in medical sciences. Her academic journey spans several prestigious institutions in Taiwan and abroad, reflecting her global perspective and commitment to scientific excellence. With expertise rooted in natural product research, pharmacological studies, and biomedical applications, she has made significant contributions to the field. Prof. Cheng continues to drive impactful research while mentoring students and collaborating with colleagues, establishing herself as a respected figure in medical education and biomedical research.

Kaohsiung Veterans General Hospital | Taiwan

Author Profile

Google Scholar

Academic Journey

Prof. Pei-Wen Cheng earned her Ph.D. degree from Kaohsiung Medical University’s Graduate Institute of Natural Products. She further advanced her career through postdoctoral research at the Faculty of Medicine, Dalhousie University and later at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital (Taiwan), where she deepened her expertise in medical sciences.

Professional Career

Prof. Cheng began her academic role as an Assistant Professor at National Sun Yat-sen University while also serving as an Assistant Researcher at Kaohsiung Veterans General Hospital. She then advanced to the position of Associate Professor at National Sun Yat-sen University and Associate Researcher at the hospital, where she contributed significantly to both teaching and research. She is currently a Professor at National Sun Yat-sen University, recognized for her impactful contributions to science and education.

Research Interests

Her primary research focuses on nanomedicine, pharmacology, and metabolic syndrome. Prof. Cheng’s innovative work bridges the gap between nanotechnology and biomedical applications, aiming to develop novel therapeutic strategies that improve human health and address critical challenges in modern medicine.

Notable Publications

Current mechanistic concepts in ischemia and reperfusion injury
Authors: Meng-Yu Wu, Giou-Teng Yiang, Wan-Ting Liao, Andy Po-Yi Tsai, Yeung-Leung Cheng, Pei-Wen Cheng, Chia-Ying Li, Chia-Jung Li
Journal: Cellular Physiology and Biochemistry
Year: 2018

Application of time series analysis in modelling and forecasting emergency department visits in a medical centre in Southern Taiwan
Authors: Wang-Chuan Juang, Sin-Jhih Huang, Fong-Dee Huang, Pei-Wen Cheng, Shue-Ren Wann
Journal: BMJ Open
Year: 2017

Resveratrol decreases fructose‐induced oxidative stress, mediated by NADPH oxidase via an AMPK‐dependent mechanism
Authors: Pei‐Wen Cheng, Wen‐Yu Ho, Yu‐Ting Su, Pei‐Jung Lu, Bo‐Zone Chen, Wen‐Han Cheng, Wen‐Hsien Lu, Gwo‐Ching Sun, Tung‐Chen Yeh, Michael Hsiao, Ching‐Jiunn Tseng
Journal: British Journal of Pharmacology
Year: 2014

Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure
Authors: Wen-Han Cheng, Pei-Jung Lu, Wen-Yu Ho, Che-Se Tung, Pei-Wen Cheng, Michael Hsiao, Ching-Jiunn Tseng
Journal: Circulation Research
Year: 2010

Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer’s disease
Authors: Yu-Te Lin, Yi-Chung Wu, Gwo-Ching Sun, Chiu-Yi Ho, Tzyy-Yue Wong, Ching-Huang Lin, Hsin-Hung Chen, Tung-Chen Yeh, Chia-Jung Li, Ching-Jiunn Tseng, Pei-Wen Cheng
Journal: Journal of Clinical Medicine
Year: 2018

Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling
Authors: Tung-Chen Yeh, Chun-Peng Liu, Wen-Han Cheng, Bo-Rong Chen, Pei-Jung Lu, Pei-Wen Cheng, Wen-Yu Ho, Gwo-Ching Sun, Jau-Cheng Liou, Ching-Jiunn Tseng
Journal: Hypertension
Year: 2014

Conclusion 

Prof. Pei-Wen Cheng exemplifies dedication to advancing scientific knowledge and fostering innovation in medical research. Her career journey from doctoral studies to professorship reflects her commitment to academic excellence and impactful research. With a focus on nanomedicine, pharmacology, and metabolic syndrome, she continues to push the boundaries of biomedical science. Her contributions extend beyond research, encompassing teaching, mentorship, and international collaborations that strengthen academic networks. As a professor, she remains committed to inspiring future scientists while pursuing groundbreaking discoveries. Prof. Cheng’s work demonstrates how multidisciplinary approaches can contribute to improved healthcare outcomes and scientific advancement on a global scale.

Dr. suresh babu katragadda | Natural Products and Medicinal Chemistry | Best Researcher Award

Published on by sciencefather

Dr. suresh babu katragadda | Natural Products and Medicinal Chemistry | Best Researcher Award

Doctorate at CSIR-Indian Institute of Chemical Technology, India

Professional Profiles

Google Scholar

Orcid

🎓 Educational Background

Dr. Katragadda Suresh Babu’s academic journey laid a strong foundation for his illustrious career in scientific research and innovation. He earned his Ph.D. (2000–2005) from CSIR-IICT, Hyderabad, with the degree awarded by Kakatiya University, Warangal, Telangana. His M.Sc. (1997–1999) was also completed at Kakatiya University, Warangal, Telangana, where he developed a keen interest in natural product chemistry. Earlier, he pursued his B.Sc. (1994–1997) at Government Degree College, Bhadrachalam, Telangana, establishing a robust base in the field of chemical sciences.

.💼 Positions and Employment

Throughout his career, Dr. Babu has held prestigious roles that have significantly contributed to the advancement of natural product research. He currently serves as a Senior Principal Scientist (2019–Present) in the Department of Natural Products and Medicinal Chemistry (DNPMC) at CSIR-IICT, Hyderabad. Previously, he worked as a Principal Scientist (2014–2019), Senior Scientist (2010–2014), and Scientist (2008–2010) in the NPC Division of CSIR-IICT, Hyderabad.

Early in his career, Dr. Babu gained international experience as a Postdoctoral Fellow (2005–2007) at the National Center for Natural Products Research (NCNPR), University of Mississippi, USA, where he further honed his expertise in medicinal chemistry.

🏆 Honors and Awards

Dr. Babu’s career is adorned with numerous prestigious accolades, highlighting his excellence in natural product chemistry and medicinal innovation. He received the OPPI Young Scientist Award (2010) from the Organization of Pharmaceutical Producers of India (OPPI), Mumbai, and the Andhra Pradesh Akademi of Sciences (APAS) Young Scientist Award (2010) for his outstanding contributions. In 2011, he was recognized with the Best Performance Award by the Director of IICT, Hyderabad.

Dr. Babu’s exemplary research earned him the Dr. A.K. Singh Memorial Young Scientist Award (2019) and fellowships from esteemed institutions such as the Andhra Pradesh Akademi of Sciences (APAS) in 2018 and the Telangana Akademi of Sciences (TAS) in 2020. These honors underscore his leadership in advancing natural product chemistry and biological sciences.

Publications Top Noted📚

Molecular structure, molecular docking, molecular dynamics simulation, and drug likeness evaluation of 3,7-dihydroxy-1,2-dimethoxyxanthone for its anticancer activity

Authors: Oladimeji, A.O.; Mountessou, B.Y.G.; Penta, P.; Babatunde, D.D.; Akintemi, E.O.; Sridar, B.; Babu, K.S.

Journal: Journal of Molecular Structure

Year: 2025

Bioactive constituents from Tinospora cordifolia (willd.): Isolation, synthesis and their immunomodulatory activity

Authors: Priya, T.S.; Siva, B.; Vemireddy, S.; Babu, K.S.

Journal: Fitoterapia

Year: 2024

Molecular Structure, Molecular Docking and Molecular Dynamic Simulation of 3,7-Dihydroxy-1,2-Dimethoxyxanthone for its Anticancer Activity

Authors: Oladimeji, A.O.; Mountessou, B.Y.G.; Penta, P.; Babatunde, D.D.; Akintemi, E.O.; Sridar, B.; Babu, K.S.

Journal: SSRN

Year: 2024

New cytotoxic spatane diterpenoids from marine alga Stoechospermum marginatum

Authors: Ashwini, K.; Siva, B.; Poornima, P.; Reddy, S.D.; Sastry, V.G.; Babu, K.S.

Journal: Fitoterapia

Year: 2024

Novel Bis-spiro-labdane type Diterpenes from Leonotis nepetifolia: Isolation, Semi-synthesis, and Evaluation of their Cytotoxic Activities

Authors: Rao, B.V.; Swain, S.; Siva, B.; Priya, T.S.; Alli, V.J.; Jadav, S.S.; Jain, N.; Ramalingam, V.; Babu, K.S.

Journal: Journal of Molecular Structure

Year: 2024

 

Dr. Cesira Giordano, Medicinal Chemistry, Women Researcher Award

Published on by sciencefather

Dr. Cesira Giordano, Medicinal Chemistry, Women Researcher Award

Doctorate at Azienda Opedaliero-Universitaria Pisana, Italy

Professional Profiles

Scopus

Orcid

🎓 Education and Academic Background

Cesira Giordano, born on January 28, 1987, holds a Master’s Degree in Molecular Biology, with a specialization in Microbiology and Virology. She furthered her expertise by completing a 2nd level Master’s in OMIC Data Analysis, reflecting her commitment to integrating cutting-edge technology into her field.

🧑‍🔬 Professional Qualifications and Current Role

Since October 2019, Cesira has held a permanent position as a Biologist Manager at the Hospital Microbiology Department of Azienda Ospedaliero-Universitaria Pisana (AOUP) in Pisa. As a Clinical Microbiologist, she is responsible for key microbiological analyses, including regional control measures in line with Tuscany’s Decree No. 16286 of 2017. Cesira’s work ensures public health laboratories maintain their high standards, particularly through her role as the Single EQA (External Quality Assessment) contact person for SD Hospital Microbiology at AOUP.

🏆 Leadership in Public Health and Tender Commissions

Cesira has been actively involved in public health laboratory management, serving as a Tender Commissioner for various public health tenders in 2023 and 2024. Her roles include:

  • June 2024: Tender Commissioner for AOUP ESTAR, overseeing consumables and accessories for public health laboratories.
  • September 2023: Tender Commissioner for AOUP, focusing on microbiological identifications and antibiotic testing (Antibiograms).
  • July 2023–Ongoing: AOUP Contact Person for the Tuscany Region regarding communications about Listeria monocytogenes.

🔬 Research Contributions and Innovations

Cesira’s research focuses on the development and application of innovative microbiological technologies. Between 2018 and 2019, she was awarded a research grant to develop Fourier Transform Infrared Spectroscopy (FTIR) technology for identifying bacteria and yeast. This work, conducted in collaboration with the University of Pisa, has laid the groundwork for bacterial typing and investigating antibiotic resistance.

Her other research highlights include:

2018: Development of rapid antibiogram protocols for multi-organ donor samples, under the supervision of Dr. Simona Barnini.

2017: Analysis of the genomes of Klebsiella pneumoniae using Next Generation Sequencing (NGS) techniques. This project aimed at identifying new genes responsible for antibiotic resistance, carried out under the leadership of Dr. Simona Barnini.

🌍 International Research and Collaboration

In 2016, Cesira expanded her research experience internationally, spending time at the University Medical Center Groningen (UMCG), Netherlands. There, she worked on whole genome sequencing of multi-resistant Klebsiella pneumoniae strains, contributing to the understanding of antibiotic resistance mechanisms under the guidance of Prof. Dr. Alexander Friedrich, Dr. Erik Bathoorn, and Dr. John Rossen.

🧪 Pioneering Work in Microbiological Diagnostics

Cesira has made significant strides in rapid diagnostic methodologies. In 2016, she played a crucial role in developing rapid molecular and phenotypic antibiograms aimed at diagnosing sepsis swiftly. The protocols she helped develop reduced diagnostic time to as little as 3-6 hours after blood culture positivity, using advanced techniques like MALDI TOF MS. These advancements have greatly improved clinical response times in critical cases, saving lives.

Publications Top Noted📚

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections

Authors: Shields, R.K., Dorazio, A.J., Tiseo, G., Doi, Y., Falcone, M.

Journal: JAC-Antimicrobial Resistance

Year: 2024

Glycine restores the sensitivity to antibiotics in multidrug-resistant bacteria

Authors: Giordano, C., Barnini, S.

Journal: Microbiology Spectrum

Year: 2024

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study from an Endemic Area

Authors: Falcone, M., Giordano, C., Leonildi, A., Barnini, S., Tiseo, G.

Journal: Clinical Infectious Diseases

Year: 2024

Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae

Authors: Tiseo, G., Galfo, V., Riccardi, N., Barnini, S., Falcone, M.

Journal: European Journal of Clinical Microbiology and Infectious Diseases

Year: 2024

Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

Authors: Lee, S.Y., Gill, C.M., Nicolau, D.P., Fang, F., Thomson, G.

Journal: Journal of Antimicrobial Chemotherapy

Year: 2023